General description
INN
Bicalutamide
Medicine type
Biological agent
EML status history
First added in 2015
(TRS
994)
for
Malignant neoplasms of prostate
Wikipedia
DrugBank
Recommendations
Section
Hormones and antihormones
- Oral > Solid: 50 mg
Indications